Q32 Bio Inc [QTTB] stock prices are down -5.39% to $2.19 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The QTTB shares have lost -17.48% over the last week, with a monthly amount glided 35.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Q32 Bio Inc [NASDAQ: QTTB] stock has seen the most recent analyst activity on February 11, 2025, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $4 from $20. Previously, BMO Capital Markets downgraded its rating to Market Perform on February 11, 2025, and dropped its price target to $3. On December 11, 2024, downgrade downgraded it’s rating to Equal Weight and revised its price target to $16 on the stock. Raymond James downgraded its rating to a Outperform and decreased its price target to $22 on December 11, 2024. Leerink Partners downgraded its rating to a Market Perform and reduced its price target to $9 on December 11, 2024. Guggenheim downgraded its rating to Neutral for this stock on December 11, 2024. In a note dated December 06, 2024, BMO Capital Markets initiated an Outperform rating and provided a target price of $64 on this stock.
The stock price of Q32 Bio Inc [QTTB] has been fluctuating between $1.35 and $53.79 over the past year. Currently, Wall Street analysts expect the stock to reach $63.83 within the next 12 months. Q32 Bio Inc [NASDAQ: QTTB] shares were valued at $2.19 at the most recent close of the market. An investor can expect a potential return of 2814.61% based on the average QTTB price forecast.
Analyzing the QTTB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.76, Equity is -4.47 and Total Capital is -0.98. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-4.68.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.09 points at the first support level, and at 1.99 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.36, and for the 2nd resistance point, it is at 2.52.
Ratios To Look Out For
It’s worth pointing out that Q32 Bio Inc [NASDAQ:QTTB]’s Current Ratio is 4.71. Further, the Quick Ratio stands at 4.71, while the Cash Ratio is 4.49.
